Skip to main content
. Author manuscript; available in PMC: 2014 Jun 13.
Published in final edited form as: J Drug Target. 2013 Sep 30;21(10):904–913. doi: 10.3109/1061186X.2013.837469

FIGURE 1. Targeted therapy with RGD-Chitosan Nanoparticles.

FIGURE 1

Binding efficiency of Alexa555 siRNA (red fluorescence) incorporated chitosan nanoparticles (CH-NP)- conjugated with RGD peptide (RGD-CH-NP) in SKOV3ip1 or A2780ip2 ovarian cancer cells (blue for nuclei) by fluorescence microscopy (Han et al., 2010).

HAN, H. D., MANGALA, L. S., LEE, J. W., SHAHZAD, M. M., KIM, H. S., SHEN, D., NAM, E. J., MORA, E. M., STONE, R. L. & LU, C. 2010. Targeted gene silencing using RGD-labeled chitosan nanoparticles. Clinical Cancer Research, 16, 3910–3922.